The biologic treatment missed the primary endpoint, but did show some improvements in those given the drug and may be better ...

Mesoblast has received FDA approval for Ryoncil, becoming the first and only cell therapy of its kind to be available in the ...

The Swedish pharma company Orexo and biotech firm Abera Bioscience announced today that they have joined forces to develop ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those ...

Mesoblast has received FDA approval for Ryoncil, becoming the first and only cell therapy of its kind to be available in the US.

Mesoblast has received FDA approval for Ryoncil, becoming the first and only cell therapy of its kind to be available in the US.

The merger of Nvelop Therapeutics and Chroma Medicine brings together a combination of epigenetic editing and in vivo ...

The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the ...